[go: up one dir, main page]

AU2001232818A1 - Hydrophilic cyanine dyes - Google Patents

Hydrophilic cyanine dyes

Info

Publication number
AU2001232818A1
AU2001232818A1 AU2001232818A AU3281801A AU2001232818A1 AU 2001232818 A1 AU2001232818 A1 AU 2001232818A1 AU 2001232818 A AU2001232818 A AU 2001232818A AU 3281801 A AU3281801 A AU 3281801A AU 2001232818 A1 AU2001232818 A1 AU 2001232818A1
Authority
AU
Australia
Prior art keywords
therapy
compounds
imaging
detection
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001232818A
Inventor
Samuel I. Achilefu
Joseph E. Bugaj
Richard B. Dorshow
Raghavan Rajagopalan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mallinckrodt Inc
Original Assignee
Mallinckrodt Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/484,319 external-priority patent/US6180086B1/en
Application filed by Mallinckrodt Inc filed Critical Mallinckrodt Inc
Publication of AU2001232818A1 publication Critical patent/AU2001232818A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/005Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056Peptides, proteins, polyamino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/001Preparation for luminescence or biological staining
    • A61K49/0013Luminescence
    • A61K49/0017Fluorescence in vivo
    • A61K49/0019Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032Methine dyes, e.g. cyanine dyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)

Abstract

Cyanine dye bioconjugates useful for diagnostic imaging and therapy are disclosed. The conjugates include several cyanine dyes with a variety of bis- and tetrakis (carboxylic acid) homologues. The compounds may be conjugated to bioactive peptides, carbohydrates, hormones, drugs, or other bioactive agents. The small size of the compounds allows more favorable delivery to tumor cells as compared to larger molecular weight imaging agents. The various dyes are useful over the range of 350-1300 nm, the exact range being dependent upon the particular dye. Use of dimethylsulfoxide helps to maintain the fluorescence of the compounds. The inventive compounds are useful for diagnostic imaging and therapy, in endoscopic applications for the detection of tumors and other abnormalities, for localized therapy, for photoacoustic tumor imaging, detection and therapy, and for sonofluorescence tumor imaging, detection and therapy.
AU2001232818A 2000-01-18 2001-01-17 Hydrophilic cyanine dyes Abandoned AU2001232818A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09484319 2000-01-18
US09/484,319 US6180086B1 (en) 2000-01-18 2000-01-18 Hydrophilic cyanine dyes
US09/757,332 US7011817B2 (en) 2000-01-18 2001-01-09 Hydrophilic cyanine dyes
US09757332 2001-01-09
PCT/US2001/001468 WO2001052744A1 (en) 2000-01-18 2001-01-17 Hydrophilic cyanine dyes

Publications (1)

Publication Number Publication Date
AU2001232818A1 true AU2001232818A1 (en) 2001-07-31

Family

ID=27047953

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001232818A Abandoned AU2001232818A1 (en) 2000-01-18 2001-01-17 Hydrophilic cyanine dyes

Country Status (5)

Country Link
EP (1) EP1250091B1 (en)
JP (1) JP2003529632A (en)
AT (1) ATE392183T1 (en)
AU (1) AU2001232818A1 (en)
WO (1) WO2001052744A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790144B2 (en) * 2000-01-18 2010-09-07 Mallinckrodt Inc. Receptor-avid exogenous optical contrast and therapeutic agents
US6663847B1 (en) * 2000-10-13 2003-12-16 Mallinckrodt Inc. Dynamic organ function monitoring agents
US7556797B2 (en) * 2000-10-16 2009-07-07 Mallinckrodt Inc. Minimally invasive physiological function monitoring agents
US6733744B1 (en) * 2000-10-16 2004-05-11 Mallinckrodt Inc. Indole compounds as minimally invasive physiological function monitoring agents
US20030105300A1 (en) * 2001-10-17 2003-06-05 Mallinckrodt Inc. Tumor targeted photodiagnostic-phototherapeutic agents
US20030105299A1 (en) * 2001-10-17 2003-06-05 Mallinckrodt Inc. Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
US20030152577A1 (en) * 2002-02-07 2003-08-14 Mallinckrodt Inc. Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications
WO2003091689A2 (en) * 2002-03-28 2003-11-06 Rutgers, The State Of University Of New Jersey Bis-transition-metal-chelate-probes
US6919333B2 (en) * 2002-11-12 2005-07-19 Rutgers, The State University Of New Jersey Bis-transition-metal-chelate probes

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8615995D0 (en) * 1986-07-01 1986-08-06 Glaxo Group Ltd Veterinary preparations
DE3721850A1 (en) * 1987-07-02 1989-01-12 Bayer Ag Indoline-carbocyanine dyes
JP3354975B2 (en) * 1992-10-06 2002-12-09 イビデン株式会社 Fluorescent labeling reagent and fluorescent immunoassay
US5631364A (en) * 1994-03-31 1997-05-20 Axis Biochemicals Asa Labelled boronic acid derivatives
AU3008595A (en) * 1994-06-30 1996-01-25 Biometric Imaging, Inc. N-heteroaromatic ion and iminium ion substituted cyanine dyes for use as fluorescence labels
IT1276833B1 (en) * 1995-10-09 1997-11-03 Sorin Biomedica Cardio Spa FLUORESCENT DYES OF THE SULFUR BENZ AND INDOCYANINE FAMILY
WO2000016806A1 (en) * 1998-09-17 2000-03-30 Nippon Kayaku Kabushiki Kaisha Remedies for photochemotherapy
DE19911102A1 (en) * 1999-03-12 2000-09-14 Few Chemicals Gmbh Wolfen New cyanine dye comprises barbituric acid or thiobarbituric acid substitutes and reactive groups, which bind carrier substances
JP4041613B2 (en) * 1999-03-12 2008-01-30 富士フイルム株式会社 Image forming material
US6180086B1 (en) * 2000-01-18 2001-01-30 Mallinckrodt Inc. Hydrophilic cyanine dyes

Also Published As

Publication number Publication date
EP1250091A1 (en) 2002-10-23
EP1250091B1 (en) 2008-04-16
EP1250091A4 (en) 2003-05-07
JP2003529632A (en) 2003-10-07
WO2001052744A1 (en) 2001-07-26
ATE392183T1 (en) 2008-05-15

Similar Documents

Publication Publication Date Title
WO2005089813A3 (en) Receptor-avid exogenous optical contrast and therapeutic agents
WO2000071162A3 (en) Cyanine and indocyanine dye bioconjugates for biomedical applications
EP1250095A4 (en) Versatile hydrophilic dyes
Wang et al. Rose-bengal-conjugated gold nanorods for in vivo photodynamic and photothermal oral cancer therapies
US20190302026A1 (en) Uniform, Functionalized, Cross-Linked Nanostructures for Monitoring pH
Zhao et al. NIR-triggered high-efficient photodynamic and chemo-cascade therapy using caspase-3 responsive functionalized upconversion nanoparticles
Liu et al. Facile synthesis of a croconaine‐based nanoformulation for optoacoustic imaging and photothermal therapy
Kopeček et al. Water soluble polymers in tumor targeted delivery
Zanganeh et al. Photoacoustic imaging enhanced by indocyanine green-conjugated single-wall carbon nanotubes
Li et al. Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S
US20100311903A1 (en) Photonic Shell-Core Cross Linked and Functionalized Nanostructures for Biological Applications
US12152182B2 (en) Polymer nanoparticles for afterglow molecular imaging
Borum et al. Supramolecular Loading of DNA Hydrogels with Dye–Drug Conjugates for Real‐Time Photoacoustic Monitoring of Chemotherapy
ES2331671T3 (en) USEFUL NON-COVALENT BIOCONJUGATES FOR DIAGNOSIS AND THERAPY.
Wu et al. Recent advances in the development and applications of conjugated polymer dots
Liu et al. Six-in-one peptide functionalized upconversion@ polydopamine nanoparticle-based ratiometric fluorescence sensing platform for real-time evaluating anticancer efficacy through monitoring caspase-3 activity
WO1999048536A3 (en) Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
Sano et al. Indocyanine green-labeled polysarcosine for in vivo photoacoustic tumor imaging
US20200078475A1 (en) Polymeric systems and uses thereof in theranostic applications
AU2001232818A1 (en) Hydrophilic cyanine dyes
Huang et al. Light‐emitting agents for noninvasive assessment of kidney function
JP2022503966A (en) Polymer chromophores, compositions containing them, and methods of preparing and using them.
Xiong et al. A tetrazine-responsive isonitrile-caged photosensitiser for site-specific photodynamic therapy
Paramio et al. Self‐assembled porphyrinoids: one‐component nanostructured photomedicines
Qin et al. TPE-based peptide micelles for targeted tumor therapy and apoptosis monitoring